Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Equities research analysts at Leede Financial issued their FY2027 earnings per share estimates for shares of Quipt Home Medical in a report released on Tuesday, February 11th. Leede Financial analyst D. Loe anticipates that the company will post earnings per share of ($0.10) for the year. The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative return on equity of 6.18% and a negative net margin of 2.66%.
Quipt Home Medical Stock Performance
NASDAQ QIPT traded down $0.03 on Thursday, reaching $2.97. 52,739 shares of the stock were exchanged, compared to its average volume of 119,482. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.73. Quipt Home Medical has a one year low of $2.30 and a one year high of $4.98. The company's 50-day simple moving average is $2.90 and its two-hundred day simple moving average is $2.84. The firm has a market capitalization of $127.98 million, a PE ratio of -19.80 and a beta of 0.57.
Institutional Investors Weigh In On Quipt Home Medical
Large investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC bought a new position in shares of Quipt Home Medical during the 3rd quarter valued at approximately $44,000. Atom Investors LP bought a new position in Quipt Home Medical during the third quarter valued at $51,000. XTX Topco Ltd bought a new position in Quipt Home Medical during the third quarter valued at $54,000. Wells Fargo & Company MN increased its position in Quipt Home Medical by 30.9% during the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company's stock valued at $73,000 after acquiring an additional 5,625 shares during the last quarter. Finally, TD Waterhouse Canada Inc. increased its position in Quipt Home Medical by 83.4% during the fourth quarter. TD Waterhouse Canada Inc. now owns 27,435 shares of the company's stock valued at $76,000 after acquiring an additional 12,479 shares during the last quarter. 42.85% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Quipt Home Medical news, VP Patrick Dennis Gamble bought 17,000 shares of Quipt Home Medical stock in a transaction dated Thursday, December 26th. The shares were purchased at an average cost of $2.45 per share, for a total transaction of $41,650.00. Following the acquisition, the vice president now directly owns 40,057 shares in the company, valued at approximately $98,139.65. This represents a 73.73 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 13.40% of the stock is owned by company insiders.
Quipt Home Medical Company Profile
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Stories
Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
